NORD report shows 63 FDA vouchers driving breakthroughs for 47 rare pediatric diseases, 43 with no prior treatments — unprecedented progress for children left behind WASHINGTON, Dec. 4, 2025 —…
NORD report shows 63 FDA vouchers driving breakthroughs for 47 rare pediatric diseases, 43 with no prior treatments — unprecedented progress for children left behind WASHINGTON, Dec. 4, 2025 —…
ASC Focus: Sg2 Forecasts Significant Growth in ASC Volume
“Surgical utilization in the ASC is expected to grow 23 percent and accounts for more than 75 percent of billable activity occurring at this care site” says Tony Guth, senior director of Sg2 Intelligence...